By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Washington State's Life Sciences Discovery Fund has awarded a $150,000 grant to a Fred Hutchinson Cancer Research Center scientist to fund a DNA sequencing technology that will be commercialized through a new company called Adaptive TCR Corporation.

The grant, which is part of a $600,000 LSDF program going to four Washington-based research teams, will be used to enhance a DNA sequencing technology that profiles T cells within the immune system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.